NCT02386839 - Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 26, 2015

Primary Completion Date

September 28, 2021

Study Completion Date

September 28, 2021

Conditions

Retinopathy of Prematurity (ROP)

Interventions

DRUG

rhIGF-1/rhIGFBP-3

"Participants who received rhIGF-1/rhIGFBP-3 in study ROPP-2008-01 (NCT01096784) will be enrolled to this study. No investigational product will be administered in this study."

Trial Locations (16)

16147

Istituto Giannina Gaslini-Istituto Pediatrico di Ricovero e, Genova

27834

Vidant Medical Center, Greenville

35128

University of Padua, Padua

36604

University of South Alabama Children's and Women's Hospital, Mobile

50134

Azienda Ospedaliera Universitaria Careggi, Florence

53715

University of Wisconsin - Madison, Madison

73104

University of Oklahoma Health Sciences Center, Oklahoma City

00168

Policlinico Universitario Agostino Gemelli, Roma

1081 HZ

VU Medical Center, Amsterdam

60-535

Ginekologiczno-Położniczy Szpital Kliniczny Uniwersytetu Medycznego w Poznan, Poznan

SE-22185

Skanes Universitetssjukhus Lund, Lund

141 86

Karolinska Universitetssjukhuset Huddinge, Stockholm

CB2 0QQ

Addenbrookes Hospital, Cambridge

KT16 0PZ

St Peter's Hospital, Chertsey

L8 7SS

Alder Hey Childrens Hospital, Liverpool

WC1E 6AU

UCL EGA Institute for Women's Health, London